对《2016 ACC/AHA/HFSA 心力衰竭新药物治疗重点更新：2013 ACCF/AHA 心力衰竭管理指南更新：美国心脏病学会基金会/美国心脏协会临床实践指南工作组及美国心力衰竭学会报告》的勘误 - Suppr

Suppr

超能文献

Correction to: 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

出版信息

Circulation. 2016 Sep 27;134(13):e298. doi: 10.1161/CIR.0000000000000460.

DOI:10.1161/CIR.0000000000000460

PMID:27672202

Abstract

摘要

相似文献

Correction to: 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Circulation. 2016 Sep 27;134(13):e298. doi: 10.1161/CIR.0000000000000460.

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

J Am Coll Cardiol. 2016 Sep 27;68(13):1476-1488. doi: 10.1016/j.jacc.2016.05.011. Epub 2016 May 20.

Circulation. 2016 Sep 27;134(13):e282-93. doi: 10.1161/CIR.0000000000000435. Epub 2016 May 20.

J Card Fail. 2016 Sep;22(9):659-69. doi: 10.1016/j.cardfail.2016.07.001. Epub 2016 Jul 6.

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

J Card Fail. 2017 Aug;23(8):628-651. doi: 10.1016/j.cardfail.2017.04.014. Epub 2017 Apr 28.

Circulation. 2017 Aug 8;136(6):e137-e161. doi: 10.1161/CIR.0000000000000509. Epub 2017 Apr 28.

J Am Coll Cardiol. 2017 Aug 8;70(6):776-803. doi: 10.1016/j.jacc.2017.04.025. Epub 2017 Apr 28.

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.

Circulation. 2016 Sep 6;134(10):e123-55. doi: 10.1161/CIR.0000000000000404. Epub 2016 Mar 29.

Correction to: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guidelineon Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.

Circulation. 2016 Sep 6;134(10):e192-4. doi: 10.1161/CIR.0000000000000452.

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

J Am Coll Cardiol. 2022 May 3;79(17):e263-e421. doi: 10.1016/j.jacc.2021.12.012. Epub 2022 Apr 1.

引用本文的文献

Comparative efficacy of different drugs in acute heart failure with renal dysfunction: a systematic review and network meta-analysis.

Front Cardiovasc Med. 2025 Jan 14;11:1444068. doi: 10.3389/fcvm.2024.1444068. eCollection 2024.

Economic Evaluations of Digital Health Interventions for Patients With Heart Failure: Systematic Review.

J Med Internet Res. 2024 Apr 30;26:e53500. doi: 10.2196/53500.

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease.

Front Cardiovasc Med. 2022 Aug 11;9:900381. doi: 10.3389/fcvm.2022.900381. eCollection 2022.

Efficacy and Safety of Ivabradine Once-Daily Prolonged-Release versus Twice-Daily Immediate-Release Formulation in Patients with Stable Chronic Heart Failure with Systolic Dysfunction: A Randomized, Double-Blind, Phase 3 Non-Inferiority (PROFICIENT) Study.

Cardiol Ther. 2020 Dec;9(2):505-521. doi: 10.1007/s40119-020-00200-8. Epub 2020 Oct 1.

High-intensity interval training for heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis.

Medicine (Baltimore). 2020 Jul 2;99(27):e21062. doi: 10.1097/MD.0000000000021062.

Short- and Long-Term Incidence of Thromboembolic Events in Takotsubo Syndrome as Compared With Acute Coronary Syndrome.

Angiology. 2019 Oct;70(9):838-843. doi: 10.1177/0003319719842682. Epub 2019 Apr 15.

Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease.

Int J Mol Sci. 2019 Feb 24;20(4):982. doi: 10.3390/ijms20040982.

The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure.

Mediators Inflamm. 2018 Feb 8;2018:9874109. doi: 10.1155/2018/9874109. eCollection 2018.

Healthcare Costs for Acute Hospitalized and Chronic Heart Failure in South Korea: A Multi-Center Retrospective Cohort Study.

Yonsei Med J. 2017 Sep;58(5):944-953. doi: 10.3349/ymj.2017.58.5.944.

The Inhibitory Effect of WenxinKeli on H9C2 Cardiomyocytes Hypertrophy Induced by Angiotensin II through Regulating Autophagy Activity.

Oxid Med Cell Longev. 2017;2017:7042872. doi: 10.1155/2017/7042872. Epub 2017 Jun 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验